Prevalence of Symptomatic Heart Failure with Reduced and with Normal Ejection Fraction in an Elderly General Population-The CARLA Study

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Tiller, Daniel ^a   Russ, Martin ^a   Greiser, Karin Halina ^a,b   Nuding, Sebastian ^a   Ebelt, Henning ^a   Kluttig, Alexander ^a   Kors, Jan A ^c   Thiery, Joachim ^d   Bruegel, Mathias ^d   Haerting, Johannes ^a   Werdan, Karl ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; GERMANY; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREVALENCE; PROGNOSIS; RISK FACTORS; STROKE VOLUME;

EID: 84875021861     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059225     Document Type: Article

References (47)

1. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, et al. (2002) Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347: 1397-402.
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, et al. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10: 933-989.
3. Luchner A, Burnett JC, Jougasaki M, Hense HW, Heid IM, et al. (2000) Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J of Hypertens 18: 1121-1128.
4. Goetze JP, Mogelvang R, Maage L, Scharling H, Schnohr P, et al. (2006) Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction. Eur Heart J 27: 3004-3010.
5. Vasan RS, Benjamin EJ, Levy D, (1995) Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 26: 1565-1574.
6. Vasan RS, Levy D, (2000) Defining Diastolic Heart Failure: A Call for Standardized Diagnostic Criteria. Circulation 101: 2118-2121.
7. Gaasch WH, Zile MR, (2004) Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med 55: 373-394.
8. Gorelik O, Almoznino-Sarafian D, Shteinshnaider M, Alon I, Tzur I, et al. (2009) Clinical variables affecting survival in patients with decompensated diastolic versus systolic heart failure. Clin Res Card 98: 224-232.
9. McMurray JJ, Stewart S, (2000) Epidemiology, aetiology, and prognosis of heart failure. Heart 83: 596-602.
10. Mosterd A, Hoes AW, (2007) Clinical epidemiology of heart failure. Heart 93: 1137-1146.
11. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, et al. (1999) Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 20: 447-455.
12. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, et al. (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. J Amer Med Assoc 289: 194-202.
13. Hoes AW, Mosterd A, Grobbee DE, (1998) An epidemic of heart failure? Recent evidence from Europe. Eur Heart J 19 (Suppl L):: L2-L9.
14. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, et al. (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355: 251-259.
15. McKee PA, Castelli WP, McNamara PM, Kannel WB, (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285: 1441-1446.
16. Kannel WB, (2000) Incidence and epidemiology of heart failure. Heart Fail Rev 5: 167-173.
17. Müller-Nordhorn J, Rossnagel K, Mey W, Willich SN, (2004) Regional variation and time trends in mortality from ischaemic heart disease: East and West Germany 10 years after reunification. J Epidemiol Commun H 58: 481-485.
18. Meisinger C, Heier M, Völzke H, Lowel H, Mitusch R, et al. (2006) Regional disparities of hypertension prevalence and management within Germany. J Hypertens 24: 293-299.
19. Greiser KH, Kluttig A, Schumann B, Kors JA, Swenne CA, et al. (2005) Cardiovascular disease, risk factors and heart rate variability in the elderly general population: design and objectives of the CARdiovascular disease, Living and Ageing in Halle (CARLA) Study. BMC Cardiovasc Disord 5: 33.
20. Greiser KH, Kluttig A, Schumann B, Swenne CA, Kors JA, et al. (2009) Cardiovascular diseases, risk factors and short-term heart rate variability in an elderly general population: the CARLA study 2002-2006. Eur J Epidemiol 24: 123-142.
21. Declaration of Helsinki (1964) Br Med J. 313: 1448-1449.
22. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, et al. (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28: 2539-2550.
23. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, et al. (2006) Recommendations for chamber quantification. Eur J Echocardiogr 7: 79-108.
24. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, et al. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440-1463.
25. Prineas RJ, Crow RS, Blackburn H (1982) The Minnesota code manual of electrocardiographic findings. standard procedures for measurement and classification.Boston: John Wright PSB.
26. van Bemmel JH, Kors JA, van Herpen G, (1990) Methodology of the modular ECG analysis system MEANS. Methods Inform Med 29: 346-353.
27. Fay M, Feuer E, (1997) Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med 16: 791-801.
28. Deddens JA, Petersen MR, (2008) Approaches for estimating prevalence ratios. Occup Environ Med 65: 501-506.
29. Moebus S, Hanisch J, Bramlage P, Lösch C, Hauner H, et al. (2008) Regional unterschiedliche Prävalenz des metabolischen Syndroms. Dtsch Arztebl 105: 207-213.
30. Völzke H, Neuhauser H, Möbus S, Baumert J, Berger K, et al. (2006) Rauchen: Regionale Unterschiede in Deutschland. Dtsch Arztebl 103: A-2784.
31. Naimi AI, Daniel M, Paquet C, Gauvin L, (2009) Associations between area-level unemployment, body mass index, and risk factors for cardiovascular disease in an urban area. Circulation 119: E305.
32. Mattiasson I, Lindgarde F, Nilsson JA, Theorell T, (1990) Threat of unemployment and cardiovascular risk factors: longitudinal study of quality of sleep and serum cholesterol concentrations in men threatened with redundancy. Br Med J 301: 461-466.
33. Task FM, McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, et al. (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J.
34. Hsich EM, Piña IL, (2009) Heart Failure in Women: A Need for Prospective Data. J Am Coll Cardiol 54: 491-498.
35. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, et al. (1998) Biochemical detection of left-ventricular systolic dysfunction. The Lancet 351: 9-13.
36. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, et al. (1997) Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. The Lancet 350: 829-833.
37. Azevedo A, Bettencourt P, Pimenta J, Frioes F, Abreu-Lima C, et al. (2007) Clinical syndrome suggestive of heart failure is frequently attributable to non-cardiac disorders-population-based study. Eur J Heart Fail 9: 391-396.
38. Le Jemtel TH, Padeletti M, Jelic S, (2007) Diagnostic and Therapeutic Challenges in Patients With Coexistent Chronic Obstructive Pulmonary Disease and Chronic Heart Failure J Am Coll Cardiol. 49: 171-180.
39. Rutten FH, Cramer MJ, Grobbee DE, Sachs APE, Kirkels JH, et al. (2005) Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 26: 1887-1894.
40. McKelvie RS, Komajda M, McMurray J, Zile M, Ptaszynska A, et al. (2010) Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial. J Card Fail 16: 128-134.
41. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, et al. (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359: 2456-2467.
42. Tehrani F, Morrissey R, Phan A, Chien C, Schwarz ER, (2010) Statin Therapy in Patients with Diastolic Heart Failure. Clin Cardiol 33: E1-E5.
43. Correa de Sa DD, Hodge DO, Slusser JP, Redfield MM, Simari RD, et al. (2010) Progression of preclinical diastolic dysfunction to the development of symptoms. Heart 96: 528-532.
44. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D, (2001) Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol 37: 1042-1048.
45. Kaelsch H, Lehmann N, Möhlenkamp S, Neumann T, Slomiany U, et al. (2010) Association of coronary artery calcium and congestive heart failure in the general population: results of the Heinz Nixdorf Recall Study. Clin Res Card 99: 175-182.
46. Vasan RS, Levy D, (1996) The Role of Hypertension in the Pathogenesis of Heart Failure: A Clinical Mechanistic Overview. Arch Intern Med 156: 1789-1796.
47. Luers C, Wachter R, Kleta S, Uhlir M, Koschack J, et al. (2010) Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction. Clin Res in Card 99: 217-226.